Search

Your search keyword '"Lleo, Alberto"' showing total 426 results

Search Constraints

Start Over You searched for: Author "Lleo, Alberto" Remove constraint Author: "Lleo, Alberto"
426 results on '"Lleo, Alberto"'

Search Results

1. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia.

2. Clinical value of plasma pTau181 to predict Alzheimer's disease pathology in a large real-world cohort of a memory clinic

3. Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease

4. Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis

5. Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease.

6. Synaptic oligomeric tau in Alzheimer’s disease — A potential culprit in the spread of tau pathology through the brain

7. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

8. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

10. Cerebrovascular co-pathology and cholinergic white matter pathways along the Lewy body continuum

11. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study

13. Sequential grey matter atrophy related to Alzheimer’s disease in adults with Down’s syndrome

14. Adults with Down syndrome show quantitative sleep electroencephalogram patterns similar to those observed in patients with Alzheimer’s disease

15. Multiomics Blood Biomarkers Predict Alzheimer from predementia with High Specificity

16. [18F]PI2620 tau deposition increases along the Alzheimer’s disease continuum in Down Syndrome and in presence of amyloid

17. SEX EFFECTS ON THE QUALITY OF SLEEP IN DOWN SYNDROME

18. Bilingualism is associated with a later age of symptom onset in bilinguals with Alzheimer’s disease positive biomarkers

19. Multiomics Blood Test for Increasing Asymptomatic AD Patients Proportion in Preventive Clinical Trials

20. Blood DNA methylomic signatures associated with CSF biomarkers of Alzheimer’s disease in the EMIF‐AD Multimodal Biomarker Discovery study

21. 4. An innovative clinical trial designed to evaluate the effects of ACI‐24.060 in Alzheimer’s Disease and in Down syndrome (ABATE Study)

23. Acoustic speech metrics that differentiate primary progressive aphasia variants depend on language typology

25. Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay

26. Prevalence of Amyloid PET Positivity in Dementia Syndromes: A Meta-analysis

27. Inflammatory biomarkers in Alzheimer's disease plasma

28. Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort

29. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

30. Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum

31. The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders

32. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

33. Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease

35. Cortical microstructural changes along the Alzheimer's disease continuum

38. Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study

39. Elevated levels of Secreted-Frizzled-Related-Protein 1 contribute to Alzheimer’s disease pathogenesis

40. Cerebrospinal fluid A beta 1–40 peptides increase in Alzheimer’s disease and are highly correlated with phospho-tau in control individuals

41. Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease

43. The frequency and influence of dementia risk factors in prodromal Alzheimer's disease

46. Consensus guidelines for lumbar puncture in patients with neurological diseases

49. Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia

50. Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease

Catalog

Books, media, physical & digital resources